Addex Provides Corporate Update and Financial Guidance – Jan 19 … – BioSpace
Skip to main content Published: Jan 19, 2023 Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, January19, 2023 – Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today provided a corporate update, including a review of its pipeline and financial guidance.“We ended 2022 with … Read more